“Nobody is safe until everyone is safe” is the defining mantra of the COVID-19 era. It captures a fundamental truth. Faced with a virus that recognizes no borders, no country is an island — and there is no substitute for international solidarity.
The June G7 summit in the UK provides political leaders of the world’s richest countries an opportunity to demonstrate that solidarity. They should seize it by agreeing on a financial plan of action to underpin humanity’s battle with COVID-19, starting with equitable access to vaccines.
The development of safe and effective COVID-19 vaccines was a scientific triumph. New partnerships involving governments, businesses, philanthropists and multilateral institutions tested, delivered and began administering vaccines in record time.
The Access to COVID-19 Tools Accelerator (ACT-A), a unique partnership between the WHO and others, provides a multilateral framework for cooperation on diagnosis, treatments and vaccines. The COVID-19 Vaccine Global Access (COVAX) facility, a key pillar in that partnership, has so far delivered 40 million doses in more than 100 countries.
Despite these achievements, vaccine inequality is widening by the day. With 16 percent of the world’s population, high-income countries account for more than half of confirmed vaccine orders, or about 4.6 billion doses — enough to vaccinate their populations several times over in some cases. With twice the population share, the poorest developing countries have half the number of confirmed orders. Supplies to sub-Saharan Africa cover less than 1 percent of the population. As wealthy countries immunize younger and healthier population groups, health workers in Mozambique, Nepal and Bolivia are fighting the pandemic without protection — and lives are being lost.
The vaccine gap highlights a stark injustice. While G7 countries are on track to achieve 70 percent coverage by the end of this year, some of the poorest countries will not reach that level before 2024 on current trends. This is ominously reminiscent of the initial response to the HIV/AIDS crisis, when Africa and other developing regions were left at the back of the queue for antiretroviral drugs that were widely available in rich countries.
The lag in delivery cost about 12 million lives.
Leaving the world’s poor behind in the race to vaccinate against COVID-19 represents a catastrophic moral failure. It is also an act of devastating self-harm. As the coronavirus spreads and mutates across unimmunized populations, it will pose a public health threat to people everywhere — including in the richest countries.
Moreover, the market disruption caused by low immunization rates in developing countries could cost the world economy US$9.2 trillion, with advanced economies accounting for half the loss.
In short, there is an overwhelming ethical, epidemiological and economic case for urgent collective action to achieve vaccine equity. The more decisively the world acts as a single human community, the more lives will be saved and the faster economies will recover.
The challenge is to ensure that sufficient vaccines are available and affordable to all countries. That challenge cannot be met through voluntary donations alone, bilateral deals outside of COVAX and the rampant vaccine nationalism that has characterized rich countries’ response so far.
This is a moment for bold action. G7 countries must urgently scale up their support for ACT-A, while supporting efforts to build vaccine self-reliance in developing countries. To build effective global defenses against COVID-19 and future pandemic threats, equitable sharing of vaccines is needed, as well as open sharing of the know-how, information and technology needed to develop complex manufacturing capabilities where they are required.
Waiving intellectual property rights for the duration of the pandemic would help facilitate sharing, increase production and drive down prices. The People’s Vaccine Alliance is mobilizing support for a waiver, and the South African and Indian governments have submitted proposals to the WTO.
What is missing is the financing plan needed to build on the foundations created by ACT-A. The G7 summit can play a critical role here. Political leaders should agree to finance a global plan aimed at achieving the vaccine ambitions of all countries by the end of this year, with everyone who wants a vaccine immunized by the end of next year. The Africa Centres for Disease Control and Prevention has set a goal of 60 percent coverage for the region by that date.
A G7 commitment of about US$30 billion a year for the next two years, supplemented by wider measures to support vaccine self-reliance, would bring that goal within reach. It would also help close ACT-A’s financing gap for this year of about US$22 billion.
South African President Cyril Ramaphosa and Norwegian Prime Minister Erna Solberg have written to governments proposing a global financial burden-sharing arrangement based on countries’ relative economic weight. We support that approach — and one of us (Brown) has proposed its adoption at the G7 summit.
Can the G7 countries afford the plan we propose?
We invite leaders to turn that question on its head: Can they afford not to make the investment?
The financing required is roughly equivalent to what G7 economies stand to lose every two weeks because of the trade dislocation resulting from limited vaccine access.
Moreover, equitable vaccination would pay for itself. The IMF estimates that advanced economies stand to gain more than US$1 trillion in additional revenues from the boost to economic recovery delivered through accelerated global vaccination — a return of US$16 for every US$1 invested.
G7 governments have some ready-made financing mechanisms at their disposal. They could agree to issue US$10 to US$15 billion in COVID-19 vaccine bonds channeled through the International Finance Facility for Immunisation.
Underwriting risk guarantees for COVID-19 financing provided through the World Bank and other multilateral financial institutions is another option. With its triple-A credit rating protected, the World Bank could mobilize US$4 to US$5 for every US$1 provided in guarantees.
Given their status as major shareholders in the IMF and the World Bank, G7 governments should be more ambitious in leveraging both institutions’ resources for the COVID-19 response. Low-income countries facing a lethal combination of reduced growth, unsustainable debt and limited fiscal space urgently need financial support.
The IMF recently estimated that an additional US$200 billion is required for pandemic containment, including financing for health systems and vaccination programs.
With the US having agreed in principle to a new US$650 billion issue of special drawing rights (SDRs, the IMF’s reserve asset) — in effect, new international money — there is an opportunity to boost liquidity and narrow the financing gap. G7 governments could agree to double the SDR allocation for low-income countries, a move that would generate US$42 billion to fight the pandemic.
They might also ask why more than 40 poor countries are still spending more on debt service than on health, and move to convert unpayable debt liabilities into life-saving vaccines.
Of course, finance is just one part of the equation. Governance also matters. It must be ensured that all governments — and civil society — have a voice in shaping international cooperation. The World Health Assembly provides a multilateral platform for that voice — and it has a key role to play in achieving vaccine equity.
Benjamin Franklin famously warned the authors of the US’ Declaration of Independence about the perils of division in the face of a powerful enemy. “We must, indeed, all hang together,” he said, “or, most assuredly, we shall all hang separately.”
Faced with this deadly pandemic, G7 leaders must now demonstrate global solidarity. Their citizens’ safety and the world’s hopes depend on it.
Gordon Brown is a former British prime minister. Winnie Byanyima is executive director of the Joint United Nations Programme on HIV/AIDS. Tedros Adhanom Ghebreyesus is director-general of the WHO. Graca Machel is founder of the Graca Machel Trust. Ken Ofori-Atta is the Ghanaian minister for finance and economic planning. Mary Robinson is a former Irish president. Kevin Watkins is chief executive officer of Save the Children UK.
Copyright: Project Syndicate
Last week, Microsoft cofounder Bill Gates and his wife, Melinda Gates, said in a statement that they have decided to end their marriage. The news immediately caused a global sensation. When my daughter heard that I was going to write a newspaper op-ed to comment on the matter, she made sure to remind me not to focus on the divorce agreement or the handling of the world’s richest couple’s wealth. Instead of talking about how much money Melinda Gates would get from the divorce, my daughter wanted me to focus on the many sacrifices she has made, and on her many
Chinese President Xi Jinping (習近平) expressed “deep concern” over the staggering rise of COVID-19 cases in India, and offered to supply medical equipment and vaccine doses to the country, but his overtures sparked debate in India’s academic and political circles about his sincerity to help, particularly as it was followed by a vulgar display of schadenfreude over the hundreds of thousands of cremations of deaths caused by the virus in the country. The vast majority of Indians were already angry and frustrated with Beijing needling the country on a number of issues, including imports from China, which were abruptly stopped
Explore within a 160km radius of central Taiwan and you would stumble across some of world’s most majestic mountains, breathtaking lakes and awe-inspiring valleys. You would also find 95 percent of the world’s most advanced chipmaking. While lacking the same postcard views as Yushan or Sun Moon Lake, Taiwan Semiconductor Manufacturing Co (TSMC) is still a treasure. The company went from being the upstart of a government industrial think tank to the most crucial chip supplier in the world, but even as it has grown into a US$540 billion company, management has stubbornly kept all state-of-the-art manufacturing capacity at just three
Given China’s regional might, it is little surprise that the nation casts a long shadow across Asia — including in its media coverage. However, we are now seeing a disturbing trend of Western media casting a favorable light on China, right as it stands accused of suppressing democracy in Hong Kong, interning Uighurs and obscuring investigations into the origins of COVID-19. At the same time, important coverage of Asian democracies, such as Taiwan’s 20-place leap in the Democracy Index last year — in the midst of a pandemic that brought major constrictions of democratic rights in many places — gets